With a rapidly expanding oncology pipeline Dr. Williams' clinical team was in need of additional qualified resources for a pivotal international Phase II oncology trial.

See how Canadian sites exceeded enrollment targets by 195% for a pivotal Phase II study.

After seeing the results of their first trial with an oncology CRO, this sponsor has since brought Scimega in to manage six additional oncology trials.

See how a collaborative approach to managing a portfolio of oncology clinical trials contributed to an overall cost savings of 9.2%.